Logo image of ORKT

ORANGEKLOUD TECHNOLOGY INC (ORKT) Stock Fundamental Analysis

NASDAQ:ORKT - Nasdaq - KYG6781F1019 - Common Stock - Currency: USD

0.621  -0.01 (-1.43%)

After market: 0.6136 -0.01 (-1.19%)

Fundamental Rating

1

ORKT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 81 industry peers in the IT Services industry. While ORKT seems to be doing ok healthwise, there are quite some concerns on its profitability. ORKT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ORKT had negative earnings in the past year.
ORKT had a negative operating cash flow in the past year.
ORKT Yearly Net Income VS EBIT VS OCF VS FCFORKT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 1M -1M

1.2 Ratios

The Return On Assets of ORKT (-52.43%) is worse than 87.65% of its industry peers.
The Return On Equity of ORKT (-105.63%) is worse than 79.01% of its industry peers.
Industry RankSector Rank
ROA -52.43%
ROE -105.63%
ROIC N/A
ROA(3y)0.02%
ROA(5y)N/A
ROE(3y)0.65%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ORKT Yearly ROA, ROE, ROICORKT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 20 -20 40 -40 -60

1.3 Margins

The Gross Margin of ORKT (44.64%) is better than 65.43% of its industry peers.
ORKT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ORKT Yearly Profit, Operating, Gross MarginsORKT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

ORKT does not have a ROIC to compare to the WACC, probably because it is not profitable.
ORKT has about the same amout of shares outstanding than it did 1 year ago.
ORKT has a worse debt/assets ratio than last year.
ORKT Yearly Shares OutstandingORKT Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M
ORKT Yearly Total Debt VS Total AssetsORKT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2M 4M 6M

2.2 Solvency

ORKT has an Altman-Z score of 6.09. This indicates that ORKT is financially healthy and has little risk of bankruptcy at the moment.
ORKT has a Altman-Z score of 6.09. This is amongst the best in the industry. ORKT outperforms 81.48% of its industry peers.
ORKT has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ORKT (0.24) is better than 61.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 6.09
ROIC/WACCN/A
WACC9.18%
ORKT Yearly LT Debt VS Equity VS FCFORKT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 1M -1M 2M 3M

2.3 Liquidity

ORKT has a Current Ratio of 1.42. This is a normal value and indicates that ORKT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.42, ORKT is in line with its industry, outperforming 40.74% of the companies in the same industry.
ORKT has a Quick Ratio of 1.42. This is a normal value and indicates that ORKT is financially healthy and should not expect problems in meeting its short term obligations.
ORKT has a Quick ratio (1.42) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42
ORKT Yearly Current Assets VS Current LiabilitesORKT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M

More info and screens

0

3. Growth

3.1 Past

ORKT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -166.67%.
Looking at the last year, ORKT shows a very negative growth in Revenue. The Revenue has decreased by -14.86% in the last year.
EPS 1Y (TTM)-166.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.87%
Revenue 1Y (TTM)-14.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-27.56%

3.2 Future

The Earnings Per Share is expected to grow by 5.48% on average over the next years.
Based on estimates for the next years, ORKT will show a decrease in Revenue. The Revenue will decrease by -1.53% on average per year.
EPS Next Y-65.33%
EPS Next 2Y-115.15%
EPS Next 3Y5.48%
EPS Next 5YN/A
Revenue Next Year-34.51%
Revenue Next 2Y-17.41%
Revenue Next 3Y-1.53%
Revenue Next 5YN/A

3.3 Evolution

ORKT Yearly Revenue VS EstimatesORKT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2M 4M 6M
ORKT Yearly EPS VS EstimatesORKT Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.05 -0.1 -0.15 -0.2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ORKT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ORKT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ORKT Price Earnings VS Forward Price EarningsORKT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ORKT Per share dataORKT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-115.15%
EPS Next 3Y5.48%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ORKT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORANGEKLOUD TECHNOLOGY INC

NASDAQ:ORKT (4/25/2025, 8:00:01 PM)

After market: 0.6136 -0.01 (-1.19%)

0.621

-0.01 (-1.43%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.51%
Inst Owner ChangeN/A
Ins Owners7.33%
Ins Owner ChangeN/A
Market Cap14.38M
Analysts82.86
Price Target5.1 (721.26%)
Short Float %4.04%
Short Ratio1.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.1
P/FCF N/A
P/OCF N/A
P/B 9
P/tB 39.09
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.3
BVpS0.07
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -52.43%
ROE -105.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.64%
FCFM N/A
ROA(3y)0.02%
ROA(5y)N/A
ROE(3y)0.65%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover2.13
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.54%
Cap/Sales 0.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z 6.09
F-Score2
WACC9.18%
ROIC/WACCN/A
Cap/Depr(3y)191.94%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.52%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-166.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-47.87%
EPS Next Y-65.33%
EPS Next 2Y-115.15%
EPS Next 3Y5.48%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.86%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-27.56%
Revenue Next Year-34.51%
Revenue Next 2Y-17.41%
Revenue Next 3Y-1.53%
Revenue Next 5YN/A
EBIT growth 1Y-174.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-31.33%
EBIT Next 3Y12.39%
EBIT Next 5YN/A
FCF growth 1Y-232.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-177.17%
OCF growth 3YN/A
OCF growth 5YN/A